Movement Alert|Equifax Rises 6.85% in Regular Trading, Post-Earnings Recovery Accelerates Amid Sector Rally

Market Focus07-29

On July 29, Equifax rose 6.85% in regular trading, trading at $189.25/share, with turnover of $152 million. The stock continued its rebound from the post-Q2 earnings sell-off, supported by broad strength across the Research & Consulting Services sector.

Equifax reported Q2 adjusted EPS of $2.25, beating the consensus estimate of $2.20 by 2.27%, while revenue of $1.70 billion grew 11% year-over-year and topped expectations. Despite the beat, shares had previously declined to around $169 after the company issued Q3 EPS guidance of $2.15-$2.25, below the Street estimate of $2.26. However, the analyst consensus mean price target of $210.86 — with major banks including Morgan Stanley ($225), JPMorgan ($210), and UBS ($220) maintaining overweight/buy ratings — positioned the stock significantly below its perceived fair value, creating conditions for a sharp recovery.

Within the Research & Consulting Services sector, peer TransUnion surged 11.04% and Thomson Reuters gained 6.78%, indicating broad sector tailwinds. Equifax's AI-driven cost reduction target doubling to $150 million and the $825 million acquisition of Circulo de Credito further reinforce the company's long-term growth narrative.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment